In light of the ROADS data, how are you choosing between intraoperative tile-based radiation therapy (TBRT) and postoperative SRT for newly diagnosed resectable brain metastases?

In light of the ROADS data, I would be cautious about broadly changing practice at this point.

While the local control benefit with cesium-131 GammaTile is impressive and biologically plausible, reported OS is much harder to reconcile. A 26% absolute improvement in 2-year OS from a local therapy int...

The authors should be congratulated for this important study, which helps provide another tool for the treatment of patients with brain metastases.

In light of ROADS, I would consider intraoperative cesium-131 tile-based radiation therapy (TBRT)/GammaTile for appropriately selected patients with new...

Very thoughtful comments from both Dr. @Dr. First Last and Dr. @Dr. First Last, and a helpful perspective on these data.

Interesting data and potentially another useful tool for these patients, but I too am struggling to reconcile the magnitude of the reported OS benefit with the observed difference...